ArticleJournal of ovarian research2026
Repurposing trifluoperazine as a potential therapeutic agent for ovarian cancer: mechanistic insight via SRC/PI3K/AKT signaling pathway inhibition.
Quan He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.